Literature DB >> 11705777

Hypothalamic dopaminergic receptor expressions in anorexia of tumor-bearing rats.

T Sato1, M M Meguid, S O Fetissov, C Chen, L Zhang.   

Abstract

Our past microdialysis studies in ventromedial hypothalamic nucleus (VMN) and lateral hypothalamic area (LHA) of changes in dopamine concentrations in response to changes in food intake [characterized as feeding pattern (changes in meal number and size)] in anorexia of cancer show abnormal presynaptic dopaminergic neurotransmission. To determine postsynaptic receptor status, studies were done in tumor-bearing (TB) and non-tumor-bearing (NTB) free-feeding control rats while continuously measuring their food intake via a rat eater meter. When TB rats developed anorexia, TB and control rats were killed, and postsynaptic D(1)- and D(2)-receptor mRNA expression in LHA and VMN were measured via RT-PCR. At anorexia, food intake decreased initially by a decrease in meal number, whereas a concurrent increase in meal size occurred for 24 h in an attempt to maintain food intake constant. Then meal size also decreased. At this time, D(1)- and D(2)-receptor mRNA expressions in LHA and VMN of TB vs. controls were significantly upregulated. Verification of D(1)- or D(2)-receptor changes to changes in meal number and size at anorexia was made by injection of intra-VMN or -LHA dopaminergic receptor antagonists. Intra-VMN D(1)-receptor antagonist (SCH-23390) in TB rats decreased food intake mainly via a decrease in meal size. Intra-VMN D(2)-receptor antagonist (sulpiride) in TB rats increased food intake via an increase in meal number and in NTB free-feeding rats by an increase in meal size. Intra-LHA D(1)-receptor antagonist in TB rats had no effect on food intake or feeding pattern. Intra-LHA D(2)-receptor antagonist in TB and in NTB free-feeding rats increased food intake via an increase in meal number. Our data provide evidence that postsynaptic dopaminergic receptor subtypes in the hypothalamus are involved in the regulation of meal size, meal number, and thus food intake in anorectic TB rats.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11705777     DOI: 10.1152/ajpregu.2001.281.6.R1907

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  8 in total

1.  Enhanced hypothalamic leptin signaling in mice lacking dopamine D2 receptors.

Authors:  Kyu Seok Kim; Ye Ran Yoon; Hyo Jin Lee; Sehyoun Yoon; Sa-Yong Kim; Seung Woo Shin; Juan Ji An; Min-Seon Kim; Se-Young Choi; Woong Sun; Ja-Hyun Baik
Journal:  J Biol Chem       Date:  2010-01-15       Impact factor: 5.157

2.  Melanocortin-4 receptor antagonist TCMCB07 ameliorates cancer- and chronic kidney disease-associated cachexia.

Authors:  Xinxia Zhu; Michael F Callahan; Kenneth A Gruber; Marek Szumowski; Daniel L Marks
Journal:  J Clin Invest       Date:  2020-09-01       Impact factor: 14.808

3.  P-selectin genotype is associated with the development of cancer cachexia.

Authors:  Benjamin H L Tan; Torill Fladvad; Theodore P Braun; Antonio Vigano; Florian Strasser; D A Christopher Deans; Richard J E Skipworth; Tora S Solheim; Sambasivarao Damaraju; James A Ross; Stein Kaasa; Daniel L Marks; Vickie E Baracos; Frank Skorpen; Kenneth C H Fearon
Journal:  EMBO Mol Med       Date:  2012-04-04       Impact factor: 12.137

4.  Proteomic profiling of the hypothalamus in a mouse model of cancer-induced anorexia-cachexia.

Authors:  R Ihnatko; C Post; A Blomqvist
Journal:  Br J Cancer       Date:  2013-09-03       Impact factor: 7.640

Review 5.  Hypothalamic integration of immune function and metabolism.

Authors:  Ana Guijarro; Alessandro Laviano; Michael M Meguid
Journal:  Prog Brain Res       Date:  2006       Impact factor: 2.453

Review 6.  Dopaminergic Control of the Feeding Circuit.

Authors:  Ja-Hyun Baik
Journal:  Endocrinol Metab (Seoul)       Date:  2021-04-06

7.  Hypothalamic food intake regulation in a cancer-cachectic mouse model.

Authors:  Jvalini T Dwarkasing; Miriam van Dijk; Francina J Dijk; Mark V Boekschoten; Joyce Faber; Josep M Argilès; Alessandro Laviano; Michael Müller; Renger F Witkamp; Klaske van Norren
Journal:  J Cachexia Sarcopenia Muscle       Date:  2013-11-13       Impact factor: 12.910

Review 8.  Pathophysiology of anorexia in the cancer cachexia syndrome.

Authors:  Chukwuemeka Charles Ezeoke; John E Morley
Journal:  J Cachexia Sarcopenia Muscle       Date:  2015-10-27       Impact factor: 12.910

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.